Skip to content

Evaluation of anterior segment inflammation in HOYA IOL iSert micro255 inserted eyes.

Evaluation of anterior segment inflammation in HOYA IOL iSert micro255 inserted eyes. - Evaluation of anterior segment inflammation in HOYA IOL iSert micro255 inserted eyes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025203
Enrollment
200
Registered
2016-12-09
Start date
2014-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Examination group: HOYA IOL iSert255 Control group
Alcon Acrysof IQ

Sponsors

Eguchi eye hospital, Miyata eye hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with bilateral senile cataract planned for elective cataract surgery (Age; 40 years old and above). 2)Calculated IOL power to be within the applicable range of the product. 3)Estimated postoperative corrective visual acuity; over 20/40. 4)Likely to fulfill all scheduled postoperative visits.

Exclusion criteria

Exclusion criteria: 1)Active inflammatory conditions (Ocular/systemic) 2)Trauma induced cataract, diabetes mellitus, diabetic retinopathy, pseudoexfoliation syndrome, glaucoma, uveitis, rubeosis iridis, retinal detachment 3)amblyopia,congenital ocular diseases 4)Fuchs' corneal dystrophy or other severe corneal dystrophy 5)Secondary IOL implantation 6)Severe intraoperative complications with potential to affect postoperative visual acuity, including anterior capsule tear, decentered capsulorrhexis, posterior capsule rupture, vitreous prolapse, zonular dialysis. 7)History of corneal transplant 8)Conditions interpreted as incompatible with the study

Design outcomes

Primary

MeasureTime frame
Laser flare meter quantification of anterior chamber flare and manual anterior chamber inflammation scoring under slit lamp examination.

Secondary

MeasureTime frame
Corrected visual acuity, corneal endothelial cell density, intraocular pressure

Countries

Japan

Contacts

Public ContactSasaki Koh

Eguchi eye hospital Eguchi eye hospital

koh-sasaki@umin.ac.jp0138-23-2272

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026